Submissions Closed!

Submission Deadline: September 1, 2024!

Order your poster for delivery to the Hotel Nikko

Abstracts

Submissions for abstracts will open soon and we encourage people of all backgrounds to submit!

We are especially interested in abstracts in the following areas: 

• Tumor classifiers and targeted therapeutics
• Toxicity reduction
• Imaging endpoints 
• Primary and secondary prevention trials                                                          
• Risk factors/risk prediction/risk reducing agents
• Disparities in breast cancer risk and outcomes
• Impact of environmental exposures
• Cell cycle and cycle control
• Post-partum weaning
• Modifiable lifestyle risk reduction for breast cancer (ie. GLP-1 agonists, leveraging microbiome)

Ideas to Implementation - Special Session

In the spirit of Silicon Valley's start up culture, our conference will close with an "Ideas to Implementation" session. We will be soliciting innovative new ideas for integrating breast cancer risk reduction into other areas of women's healthcare and the development of new products. Selected teams will have the opportunity to present their proposal to a panel of biotech investors, FDA leaders, and scientists who will judge ideas on their feasibility and promise in the style of Shark Tank. Our hope is this session will foster productive conversations and potential partnerships between academia and industry.

Potential areas for integrating breast cancer risk reduction include:

• Managing menstrual cycles and pregnancy prevention
• Postpartum weaning
• Hormone replacement therapy